These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Relation between helper and suppressive/cytotoxic T lymphocytes in the peripheral blood in patients with dilated cardiomyopathy]. Smalcelj A; Duraković Z; Batinić D; Bogdan I; Grgić V Acta Med Iugosl; 1991; 45(1):3-13. PubMed ID: 1827936 [TBL] [Abstract][Full Text] [Related]
29. [Immunoregulatory lymphocyte subpopulations in patients with dilated and hypertrophic cardiomyopathies]. Chumburidze VB; Iurenev AP; Tabazari DZ; Dzidziguri LM; Krukovskaia ZV Ter Arkh; 1986; 58(10):59-62. PubMed ID: 2879362 [TBL] [Abstract][Full Text] [Related]
30. Immune function during ageing in man: relation between serological abnormalities and cellular immune status. Lokhorst HM; van der Linden JA; Schuurman HJ; Gmelig Meyling FH; Bast EJ; de Gast GC Eur J Clin Invest; 1983 Jun; 13(3):209-14. PubMed ID: 6409645 [TBL] [Abstract][Full Text] [Related]
31. T-lymphocyte subsets as noninvasive markers of cardiomyopathy. Kanda T; Yokoyama T; Ohshima S; Yuasa K; Watanabe T; Suzuki T; Murata K Clin Cardiol; 1990 Sep; 13(9):617-22. PubMed ID: 2145109 [TBL] [Abstract][Full Text] [Related]
32. Immunopathogenesis of dilated cardiomyopathy. Evidence for the role of TH2-type CD4+T lymphocytes and association with myocardial HLA-DR expression. Kuethe F; Braun RK; Foerster M; Schlenker Y; Sigusch HH; Kroegel C; Figulla HR J Clin Immunol; 2006 Jan; 26(1):33-9. PubMed ID: 16418801 [TBL] [Abstract][Full Text] [Related]
34. [Value of immunological studies in various forms of cardiomyopathy]. Iurenev AP; Chumburidze VB; Polianskaia IS; Iazdovskiĭ VV; Krukovskaia ZV Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):101-6. PubMed ID: 3501296 [TBL] [Abstract][Full Text] [Related]
35. HLA-DR antigen linkage of anti-beta receptor antibodies in idiopathic dilated and ischaemic cardiomyopathy. Limas CJ; Limas C Br Heart J; 1992 May; 67(5):402-5. PubMed ID: 1327038 [TBL] [Abstract][Full Text] [Related]
36. Immunohistochemistry in dilated cardiomyopathy. Kühl U; Noutsias M; Schultheiss HP Eur Heart J; 1995 Dec; 16 Suppl O():100-6. PubMed ID: 8682073 [TBL] [Abstract][Full Text] [Related]
37. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Maisch B; Deeg P; Liebau G; Kochsiek K Am J Cardiol; 1983 Nov; 52(8):1072-8. PubMed ID: 6356861 [TBL] [Abstract][Full Text] [Related]
38. Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Noutsias M; Pauschinger M; Schultheiss H; K hl U Med Sci Monit; 2002 Jul; 8(7):CR478-87. PubMed ID: 12118194 [TBL] [Abstract][Full Text] [Related]
39. Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kurz P; Köhler H; Meuer S; Hütteroth T; Meyer zum Büschenfelde KH Kidney Int; 1986 Jun; 29(6):1209-14. PubMed ID: 3489122 [TBL] [Abstract][Full Text] [Related]
40. Immunological disorders in patients with dilated cardiomyopathy. With special reference to the production of interleukin-2 and the expression of interleukin-2 receptors in the patients' peripheral blood lymphocytes. Koike S Jpn Heart J; 1989 Nov; 30(6):799-807. PubMed ID: 2632833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]